Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer
Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
We aimed to develop a nomogram to predict prognosis of HR+ HER2- breast cancer patients and guide the application of postoperative adjuvant chemotherapy.
We identified 310 eligible HR+ HER- breast cancer patients and randomly divided the database into a training group and a validation group. The endpoint was disease free survival (DFS). Concorda...
Alternative Titles
Full title
Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ac69318d2764446f8203fd0cfe208fc7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac69318d2764446f8203fd0cfe208fc7
Other Identifiers
ISSN
1179-1322
E-ISSN
1179-1322
DOI
10.2147/CMAR.S459714
